Hapvida Reports 41% Profit Drop and Loss of 114,000 Beneficiaries in Q1 2026
Brazilian healthcare operator Hapvida released its first-quarter 2026 financial results, revealing a significant decline in key performance indicators compared to the same period in 2025. The company's adjusted net profit fell by 41.4% to R$244 million, while its health beneficiary base shrunk by 114,100 individuals, totaling 8.684 million. This reduction was widespread across most regions, with the Southeast experiencing the largest outflow, although the Central-West region saw slight growth. Despite a 5.2% increase in net revenue driven by price adjustments, operational efficiency worsened. The cash loss ratio rose to 72.2%, and administrative expenses increased as a percentage of revenue. Furthermore, Hapvida's net debt grew by 24% to R$5.165 billion, raising its leverage ratio. While sequential comparisons to the fourth quarter of 2025 showed improvement due to seasonal factors, the annual trend highlights challenges in retaining individual plan subscribers and managing rising costs. Conversely, the dental plans segment added nearly 250,000 beneficiaries, and the company maintained positive free cash flow, though insufficient to reduce its growing debt burden.
Wire timeline
Hapvida Reports 41% Profit Drop and Loss of 114,000 Beneficiaries in Q1 2026
Brazilian healthcare operator Hapvida released its first-quarter 2026 financial results, revealing a significant decline in key performance indicators compared to the same period in 2025. The company's adjusted net profit fell by 41.4% to R$244 million, while its health beneficiary base shrunk by 114,100 individuals, totaling 8.684 million. This reduction was widespread across most regions, with the Southeast experiencing the largest outflow, although the Central-West region saw slight growth. Despite a 5.2% increase in net revenue driven by price adjustments, operational efficiency worsened. The cash loss ratio rose to 72.2%, and administrative expenses increased as a percentage of revenue. Furthermore, Hapvida's net debt grew by 24% to R$5.165 billion, raising its leverage ratio. While sequential comparisons to the fourth quarter of 2025 showed improvement due to seasonal factors, the annual trend highlights challenges in retaining individual plan subscribers and managing rising costs. Conversely, the dental plans segment added nearly 250,000 beneficiaries, and the company maintained positive free cash flow, though insufficient to reduce its growing debt burden.
Exame